More than a year after the public consultation closed, EMA and the Commission have announced moves that aim to clear the regulatory logjam holding back commercialisation of therapies based on tissues, cells and genes

The apps will improve self-care, adherence to therapy and long-term outcomes in this common, chronic condition, its developers say. The app for healthcare professionals will be one of the first such m-health apps to be CE-approved

Fears that the EU will give up its involvement in health won’t go away. A big concern is that the next president of the Commission “might abolish” its responsibilities, says Austria’s director-general for health

Public-private drug research programme has - as yet - only provided limited examples of how it is delivering on its goals, an independent evaluation concludes

Only 5 of 19 cities bidding to host the European Medicines Agency would attract enough current employees for operations to continue as normal. Moving to one of the 8 least popular cities risks permanent damage, the agency warns